“The IDC Risk Calculator can provide a glimpse into the future for individuals with diabetes and obesity, and demonstrate the impact usual medical care versus metabolic surgery would have on their risk of death or major complications,” said lead study author Ali Aminian, MD, FACS, FASMBS, a bariatric surgeon and associate professor of surgery at the Cleveland Clinic, OH. The risk calculation is made based on a combination of variables including the patient’s age, medical history, body mass index, diabetes control, and medication usage. Using rigorous statistical analysis and machine learning, accurate prediction models were created and integrated into the new Individualized Diabetes Complication (IDC) Risk Calculator, which provides a 10-year personalized risk score if a patient continues his or her current treatment or undergoes metabolic surgery. Now these same researchers have taken this data and in a new study identified the factors that contribute to four potential adverse outcomes from diabetes - death, cardiovascular event, heart failure and diabetic kidney disease. The study compared the outcomes of 13,722 patients with type 2 diabetes and obesity (2,287 metabolic surgery patients and 11,435 closely matched patients who were eligible for surgery but received standard medical therapy). According to a recent study in the Journal of the American Medical Association by researchers at the Cleveland Clinic, patients who had metabolic surgery were 39 percent less likely to experience a heart-, stroke-, or diabetic kidney-related complication and 41 percent were less likely to die from any cause. Studies have shown that for most patients with obesity, metabolic surgery, which includes procedures such as sleeve gastrectomy and gastric bypass, is superior to medical therapy in improving type 2 diabetes and in lowering the risk of heart attacks, strokes and other major adverse cardiovascular events. 5, 2019 – A new web-based risk calculator can accurately predict the likelihood a patient with type 2 diabetes and obesity will die or develop serious complications including a heart attack, heart failure and diabetic kidney disease (nephropathy) within the next 10 years depending on whether they have metabolic (bariatric) surgery or continue with standard medical treatment, according to a new study* presented today by Cleveland Clinic researchers at the 36th American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting at ObesityWeek 2019. 5, 2019Įvidence-Based Prediction Tool Designed to Help Patients Decideīetween Metabolic Surgery and Standard Medical Therapy

Pathway for Endorsement for New Devices and ProceduresĮMBARGOED UNTIL: 6 a.m.Essentials of Bariatric & Metabolic Surgery App.Treat your Obesity | Patient Learning Center.

Death date calculator